Search Results - "Shirsat, Neelam Vishwanath"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    ETV/Pea3 family transcription factor-encoding genes are overexpressed in CIC-mutant oligodendrogliomas by Padul, Vijay, Epari, Sridhar, Moiyadi, Aliasgar, Shetty, Prakash, Shirsat, Neelam Vishwanath

    Published in Genes chromosomes & cancer (01-12-2015)
    “…Oligodendrogliomas with combined loss of chromosome arms 1p and 19q are known to be particularly sensitive to chemotherapy, and the CIC gene located on 19q is…”
    Get full text
    Journal Article
  2. 2

    MiR-224 expression increases radiation sensitivity of glioblastoma cells by Upraity, Shailendra, Kazi, Sadaf, Padul, Vijay, Shirsat, Neelam Vishwanath

    “…•MiR-224 expression in established glioblastoma cell lines and sporadic tumor tissues is low.•Exogenous miR-224 expression was found to increase radiation…”
    Get full text
    Journal Article
  3. 3

    Restoration of miR-193a expression is tumor-suppressive in MYC amplified Group 3 medulloblastoma by Bharambe, Harish Shrikrishna, Joshi, Annada, Yogi, Kedar, Kazi, Sadaf, Shirsat, Neelam Vishwanath

    Published in Acta neuropathologica communications (14-05-2020)
    “…Medulloblastoma, a highly malignant pediatric brain tumor, consists of four molecular subgroups, namely WNT, SHH, Group 3, and Group 4. The expression of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Real-Time PCR Assays on Formalin-Fixed, Paraffin-Embedded Medulloblastomas by Kunder, Ratika, Shirsat, Neelam Vishwanath

    “…Real-time PCR technology has been instrumental in contributing toward biomarker discovery, classification of tumors as well as risk stratification of patients…”
    Get more information
    Journal Article
  6. 6

    Downregulation of CRX, a Group 3-specific oncogenic transcription factor, inhibits TGF-β/activin signaling in medulloblastoma cells by Masurkar, Shalaka Arun, Deogharkar, Akash, Bharambe, Harish Shrikrishna, Shirsat, Neelam Vishwanath

    “…Medulloblastoma, the most common malignant brain tumor in children, consists of four molecular subgroups WNT, SHH, Group 3, and Group 4. Group 3 has the worst…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Tamoxifen-Induced Cell Death of Malignant Glioma Cells Is Brought About by Oxidative-Stress-Mediated Alterations in the Expression of BCL2 Family Members and Is Enhanced on miR-21 Inhibition by Harmalkar, Mugdha, Upraity, Shailendra, Kazi, Sadaf, Shirsat, Neelam Vishwanath

    Published in Journal of molecular neuroscience (01-10-2015)
    “…High-grade gliomas are refractory to the current mode of treatment primarily due to their inherent resistance to cell death. Tamoxifen has been reported to…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Autophagy inhibition impairs the invasion potential of medulloblastoma cells by Paul, Raikamal, Bharambe, Harish, Shirsat, Neelam Vishwanath

    Published in Molecular biology reports (01-07-2020)
    “…Medulloblastoma, a highly malignant pediatric brain tumor, consists of four distinct molecular subgroups called WNT, SHH, Group 3, and Group 4 that differ in…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway by Gokhale, Amit, Kunder, Ratika, Goel, Atul, Sarin, Rajiv, Moiyadi, Aliasgar, Shenoy, Asha, Mamidipally, Chandrasekhar, Noronha, Santosh, Kannan, Sadhana, Shirsat, Neelam Vishwanath

    “…Medulloblastoma is a malignant brain tumor that occurs predominantly in children. Current risk stratification based on clinical parameters is inadequate for…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway by Gokhale, Amit, Kunder, Ratika, Goel, Atul, Sarin, Rajiv, Moiyadi, Aliasgar, Shenoy, Asha, Mamidipally, Chandrasekhar, Noronha, Santosh, Kannan, Sadhana, Shirsat, Neelam Vishwanath

    “…Aim: Medulloblastoma is a malignant brain tumor that occurs predominantly in children. Current risk stratification based on clinical parameters is inadequate…”
    Get full text
    Journal Article